- Home
- HP vs IMCR Comparison
HP vs IMCR Comparison
Compare HP & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HP
- IMCR
- Stock Information
- Founded
- HP 1920
- IMCR 2008
- Country
- HP United States
- IMCR United Kingdom
- Employees
- HP N/A
- IMCR N/A
- Industry
- HP Oil & Gas Production
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HP Energy
- IMCR Health Care
- Exchange
- HP Nasdaq
- IMCR Nasdaq
- Market Cap
- HP 1.6B
- IMCR 1.8B
- IPO Year
- HP N/A
- IMCR 2021
- Fundamental
- Price
- HP $20.20
- IMCR $37.20
- Analyst Decision
- HP Hold
- IMCR Buy
- Analyst Count
- HP 11
- IMCR 9
- Target Price
- HP $22.20
- IMCR $57.00
- AVG Volume (30 Days)
- HP 2.1M
- IMCR 316.1K
- Earning Date
- HP 08-06-2025
- IMCR 11-05-2025
- Dividend Yield
- HP 4.95%
- IMCR N/A
- EPS Growth
- HP N/A
- IMCR N/A
- EPS
- HP N/A
- IMCR N/A
- Revenue
- HP $3,428,058,000.00
- IMCR $356,145,000.00
- Revenue This Year
- HP $38.18
- IMCR $31.83
- Revenue Next Year
- HP $4.65
- IMCR $8.50
- P/E Ratio
- HP N/A
- IMCR N/A
- Revenue Growth
- HP 25.92
- IMCR 26.78
- 52 Week Low
- HP $14.65
- IMCR $23.15
- 52 Week High
- HP $37.46
- IMCR $39.33
- Technical
- Relative Strength Index (RSI)
- HP 61.83
- IMCR 76.55
- Support Level
- HP $19.50
- IMCR $31.85
- Resistance Level
- HP $21.29
- IMCR $33.08
- Average True Range (ATR)
- HP 0.81
- IMCR 1.28
- MACD
- HP 0.17
- IMCR 0.50
- Stochastic Oscillator
- HP 72.68
- IMCR 100.00
About HP Helmerich & Payne Inc.
Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.